| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/1933719107302959 Activation of Toll-like Receptors 2 or 3 and Preterm Delivery in the MouseDepartment of Obstetrics and Gynecology, Evanston Northwestern Healthcare, Evanston, Illinois
Advanced Cell Technology,Worchester, Massachusetts
Department of Obstetrics and Gynecology, Evanston Northwestern Healthcare, Evanston, Illinois, e-hirsch{at}northwestern.edu The objective of this study is to test whether the activation of toll-like receptors (TLRs) 2 and 3 (innate immune receptors for gram-positive and viral pathogens, respectively) can induce preterm delivery. One uterine horn of preterm pregnant CD-1 mice at approximately 75% of gestation was injected with TLR-2 ligands (lipoteichoic acid [LTA] or peptidoglycan [PGN]) or the TLR-3 ligand polyinosinic:cytidylic acid (poly[I:C]). Preterm delivery was recorded. In a separate group of mice, tissue mRNAs were quantified by reverse transcriptase polymerase chain reaction 5 hours after treatment with PGN or poly(I:C). Intrauterine PGN and LTA induced preterm delivery, reaching 100% at maximal doses. Intraperitoneal PGN also induced preterm delivery but at lower rates (maximum = 55%). Intrauterine poly(I:C) induced preterm birth in up to 31% of mice. Poly(I:C) induced uterine interferon ß and chemokine (C-C motif) ligand 5 (CCL5, also known as RANTES) but not interleukin 1ß, tumor necrosis factor, or lipopolysaccharide-induced CXC chemokine. PGN did not alter these mRNAs when compared with saline. Neither treatment induced gene expression in fetal membranes. Activation of either TLR-2 or -3 can induce preterm delivery in the mouse. Activation of TLR-3 with poly(I:C) induces interferon ß and the chemokine CCL5 in uterine tissues but not in fetal membranes.
Key Words: Toll-like receptors preterm birth animal model chemokines.
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



